Neurosteer develops a pocket-sized, medical-grade device utilizing hdrEEG technology to provide real-time analysis of brain activity for the early detection of neurological disorders such as Alzheimer's and Parkinson's. This non-invasive platform enables continuous monitoring and objective biomarker assessment, facilitating timely interventions and improved patient outcomes.
Funding
$8.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for detecting neurological disorders often rely on expensive, bulky equipment and are limited to clinical settings. This makes frequent monitoring and early detection challenging, hindering timely intervention for conditions like Alzheimer's and Parkinson's disease.
Solution
Neurosteer offers a pocket-sized, medical-grade device that uses high-definition resolution electroencephalography (hdrEEG) technology to analyze brain activity in real-time. The system employs an adhesive forehead strip connected to a sensor that wirelessly transmits data to the cloud, where advanced algorithms decompose the single hdrEEG channel. The interpreted results are displayed on a web-based dashboard, providing objective biomarkers for assessing brain health. This platform enables affordable screening and continuous patient monitoring outside of traditional clinical environments.
Target Audience
The primary target audience includes clinicians, neurologists, and researchers focused on early detection, monitoring, and treatment of neurological disorders, as well as individuals seeking proactive brain health management.
Features
- Pocket-sized, wireless EEG sensor for convenient and portable brain activity monitoring
- Single-channel hdrEEG technology to distinguish activity of different neural networks
- Real-time data analysis and interpretation via cloud-based algorithms
- Web-based dashboard for displaying brain activity metrics and trends
- Continuous monitoring capabilities for assessing brain function during daily routines
- Objective biomarkers for early detection of cognitive decline and neurological disorders
- Non-invasive and medical-grade device suitable for a wide range of applications